CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −75,633 | $16.07 | $1.2M | 220,937 |
| 2025-11-17 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −18,572 | $16.11 | $299K | 298,070 |
| 2025-11-17 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,500 | $17.07 | $26K | 296,570 |
| 2025-11-14 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −110,228 | $16.02 | $1.8M | 316,642 |
| 2025-11-13 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,111 | $16.00 | $18K | 426,870 |
| 2025-09-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +701 | $9.13 | $6K | 14,788 |
| 2025-08-07 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2025-08-07 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2025-08-07 | Warner Douglas J Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-08-07 | Harris Todd President and CEO | Grant or award · Stock Option (Right to Buy) | +570,000 | 570,000 | ||
| 2025-06-18 | KAPLAN GILLA Director | Sale | −9,568 | $9.78 | $94K | 28,231 |
| 2025-06-17 | KAPLAN GILLA Director | Sale | −10 | $10.35 | $104 | 37,799 |
| 2025-06-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +11,813 | $10.13 | $120K | 10,259,291 |
| 2025-06-16 | KAPLAN GILLA Director | Sale | −6,814 | $10.38 | $71K | 37,809 |
| 2025-06-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +120,167 | $10.20 | $1.2M | 10,247,478 |
| 2025-06-13 | KAPLAN GILLA Director | Sale | −15,000 | $10.31 | $155K | 44,623 |
| 2025-06-12 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +31,307 | $10.20 | $319K | 10,127,311 |
| 2025-06-12 | KAPLAN GILLA Director | Sale | −30,000 | $10.31 | $309K | 59,623 |
| 2025-06-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +186,850 | $10.19 | $1.9M | 10,096,004 |
| 2025-06-05 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +213,334 | $10.04 | $2.1M | 9,909,154 |
Page 3 of 9 · 170 trades